Early Life Stress and Major Depressive Disorder-An Update on Molecular Mechanisms and Synaptic Impairments

被引:2
|
作者
Bertollo, Amanda Gollo [1 ]
Galvan, Agatha Carina Leite [1 ]
Dallagnol, Claudia [1 ]
Cortez, Arthur Dellazeri [1 ]
Ignacio, Zuleide Maria [1 ]
机构
[1] Fed Univ Fronteira Sul, Grad Program Biomed Sci, Lab Physiol Pharmacol & Psychopathol, BR-89815899 Chapeco, SC, Brazil
关键词
Early life stress; Major depressive disorder; Epigenetic; Neurotransmitter; Neuronal signaling; TRYPTOPHAN DEPLETION; INFLAMMATORY MARKERS; SYSTEM FUNCTION; CHILDHOOD; BEHAVIOR; NEUROSCIENCE; METHYLATION; EXPERIENCES; EXPRESSION; REACTIVITY;
D O I
10.1007/s12035-024-03983-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Early life stress (ELS), characterized as abuse, neglect, and abandonment, can cause several adverse consequences in the lives of affected individuals. ELS experiences can affect an individual's development in variable ways, persisting in the long term and promoting lasting impacts, considering that early exposure to stressors can be biologically incorporated, as prolonged stimulation of stress response systems affects the development of the brain structure and other body systems, increasing the risk of diseases associated with stress and cognitive impairment. This type of stress increases the risk of developing major depressive disorder (MDD) in a severe form that does not respond adequately to traditional antidepressant treatments. Several alterations are studied as mechanisms that relate ELS with MDD, such as epigenetic alterations, neurotransmitters, and neuronal signaling. This review discusses research that brings evidence about the ELS mechanisms involved in synaptic impairments and MDD. The processes involved in epigenetic changes and the HPA axis are highlighted, as well as changes in neurotransmitters and neuronal signaling mechanisms.
引用
收藏
页码:6469 / 6483
页数:15
相关论文
共 50 条
  • [21] Emerging drugs for major depressive disorder: an update
    Rizvi, Sakina J.
    Kennedy, Sidney H.
    EXPERT OPINION ON EMERGING DRUGS, 2012, 17 (03) : 285 - 294
  • [22] Protein Biomarkers in Major Depressive Disorder: An Update
    Woods, Alisa G.
    Wormwood, Kelly L.
    Iosifescu, Dan V.
    Murrough, James
    Darie, Costel C.
    ADVANCEMENTS OF MASS SPECTROMETRY IN BIOMEDICAL RESEARCH, 2ND EDITION, 2019, 1140 : 585 - 600
  • [23] Differential Diagnosis of Major Depressive Disorder and Bipolar Disorder: Genetic and Hormonal Assessment and the Influence of Early-Life Stress
    Menezes, Itiana Castro
    von Werne Baes, Cristiane
    Figaro-Drumond, Fernanda Viana
    Dias Macedo, Brisa Burgos
    Bueno, Ana Carolina
    Lacchini, Riccardo
    Feijo de Mello, Marcelo
    de Castro, Margaret
    Juruena, Mario Francisco
    BRAIN SCIENCES, 2022, 12 (11)
  • [24] Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder
    Papakostas, G. I.
    Ionescu, D. F.
    MOLECULAR PSYCHIATRY, 2015, 20 (10) : 1142 - 1150
  • [25] Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder
    G I Papakostas
    D F Ionescu
    Molecular Psychiatry, 2015, 20 : 1142 - 1150
  • [26] Biological correlates of early life stressful events in major depressive disorder
    Silva, Rosana Carvalho
    Maffioletti, Elisabetta
    Gennarelli, Massimo
    Baune, Bernhard T.
    Minelli, Alessandra
    PSYCHONEUROENDOCRINOLOGY, 2021, 125
  • [27] Exploring the Synaptic Basis of Chronotherapy for Major Depressive Disorder
    Klein, Matthew
    Malinow, Roberto
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S559 - S559
  • [28] Synaptic neurotransmission in euthymic patients with major depressive disorder
    Nikolaus, S.
    Hautzel, H.
    Heinzel, A.
    Mueller, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S277 - S277
  • [29] Quality of life in major depressive disorder
    Guermazi, A.
    Smaoui, N.
    Omri, S.
    Lajmi, I.
    Feki, R.
    Bouali, M. Maalej
    Charfi, N.
    Zouari, N.
    Ben Thabet, J.
    Zouari, L.
    Maalej, M.
    EUROPEAN PSYCHIATRY, 2020, 63 : S374 - S374
  • [30] WORKING MEMORY IMPAIRMENTS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD)
    Nazarboland, N.
    EUROPEAN PSYCHIATRY, 2010, 25